mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
9e-06 |
mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-05 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-05 |
mRNA |
AZD6482 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
2e-05 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-05 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
2e-05 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
3e-05 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
3e-05 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
4e-05 |
mRNA |
TGX221 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
5e-05 |